前列腺多参数磁共振能否使PSA升高且有良性前列腺增大手术指征的患者避免活检
研究纳入40例因良性前列腺增大有手术指征且PSA升高的男性,前瞻性入组并回顾性分析,所有患者行1.5T多参数磁共振后接受经直肠超声引导活检。以活检病理为参考标准,评估两种场景下mpMRI对任何前列腺癌和临床显著前列腺癌的诊断效能,结论认为mpMRI高阴性预测值可能避免不必要的活检。
要点
- 场景1(PIRADS 1-2为阴性)对临床显著前列腺癌的阴性预测值为95%,但特异度仅59.4%。
- 场景2(PIRADS 1-3为阴性)对临床显著前列腺癌的阴性预测值为93.8%,特异度93.8%、准确率90%。
- 临床显著前列腺癌定义为ISUP≥2,活检病理为参考标准。
核心结论
- 前列腺mpMRI凭借高阴性预测值,可能使PSA升高且因良性前列腺增大有手术指征的患者避免不必要的活检。
研究设计与样本
- 40例因良性前列腺增大有手术指征且PSA升高的男性前瞻性入组并回顾性分析,所有患者活检前接受1.5 Tesla mpMRI,以经直肠超声引导活检病理为参考标准。
- mpMRI为PIRADS 3且存在局灶性病变、PIRADS 4或PIRADS 5时,采用融合引导技术额外取材。
诊断标准与关键数值
- 场景1(PIRADS 1和2视为阴性)对任何前列腺癌的敏感度76.9%、特异度63%、PPV 50%、NPV 85%、准确率67.5%。
- 场景1对临床显著前列腺癌的敏感度87.5%、特异度59.4%、PPV 35%、NPV 95%、准确率65%。
- 场景2(PIRADS 1、2和3视为阴性)对任何前列腺癌的敏感度53.8%、特异度96.3%、PPV 87.5%、NPV 81.3%、准确率82.5%。
- 场景2对临床显著前列腺癌的敏感度75%、特异度93.8%、PPV 75%、NPV 93.8%、准确率90%。
- 临床显著前列腺癌定义为ISUP≥2。
临床应用与阅片要点
- 作者认为,对于PSA升高且因良性前列腺增大有手术指征的患者,前列腺mpMRI可能避免不必要的活检,依据是其高阴性预测值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: To evaluate the clinical dilemma of men with surgical indication due to benign prostatic enlargement (BPE) and concomitant elevated PSA, we analysed if multiparametric magnetic resonance imaging (mpMRI) could safely prescind the prostate biopsy.
METHODS: Forty men with surgical indication due to BPE and concomitantly elevated PSA levels were prospectively enrolled and retrospectively analysed. All patients underwent 1.5 Tesla mpMRI prior to TRUS-guided biopsies. In cases where mpMRI was PIRADS 3 with focal lesions, PIRADS 4 or PIRADS 5, additional fragments were obtained with the fusion guided technique. Biopsy histopathological results were used as the standard of reference. Two scenarios were evaluated: scenario 1, considering mpMRI PIRADS 1 and 2 as negative; and scenario 2, considering PIRADS 1, 2 and 3 as negative. Clinically significant prostate cancer (CsPCa) was defined as ISUP ≥ 2.
RESULTS: Median age was 68 years, median PSA was 9.41 (6.40-19.54) and median prostatic volume was 116.5 cc (IQR 86.5-155). Scenario 1 mpMRI sensitivity, specificity, PPV, NPV and accuracy for any prostate cancer on prostate biopsy was 76.9%, 63%, 50%, 85% and 67.5%. For csPCa, they were 87.5%, 59.4%, 35%, 95% and 65%, respectively, for the same measures. Scenario 2 the sensitivity, specificity, PPV, NPV and accuracy of mpMRI for any prostate cancer on prostate biopsy was 53.8%, 96.3%, 87.5%, 81.3% and 82.5%. For csPCa, they were 75%, 93.8%, 75%, 93.8% and 90%, respectively, for the same measures.
CONCLUSION: Prostate mpMRI may prevent unnecessary biopsies in patients with elevated PSA and surgical indications due to BPE, given its high negative predictive value.
引用
- Wroclawski ML, Kayano PP, Amaral BS, et al. Can multiparametric magnetic resonance of the prostate avoid biopsies in patients with elevated PSA and surgical indication for benign prostatic enlargement? Abdom Radiol (NY). 2020. PMID: 31974659. doi:10.1007/s00261-020-02411-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。